Increased sensitivity to vecuronium and prolonged duration of its action in patients with end-stage renal failure

Journal of Clinical Anesthesia

Volumn 13, Issue 3, 2001, Pages 193-197

  Sakamoto, Hiroshi ^a   Takita, Koichi ^a   Kemmotsu, Osamu ^a   Morimoto, Yuji ^a   Mayumi, Takahisa ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Biotransformation; Hemodialysis; Kidney failure, chronic; Kidney transplantation; Vecuronium bromide: pharmacokinetics

Indexed keywords

3 DEACETYLVECURONIUM; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; BILIRUBIN; BROTIZOLAM; CALCIUM; CREATININE; CYCLOSPORIN; FENTANYL; ISOFLURANE; NITROUS OXIDE; POTASSIUM; PREDNISOLONE; PROTEIN; RANITIDINE; THIAMYLAL; UNCLASSIFIED DRUG; VECURONIUM; VECURONIUM DERIVATIVE;

ADULT; ARTICLE; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG MECHANISM; DRUG METABOLISM; DRUG SENSITIVITY; ELECTIVE SURGERY; ENDOTRACHEAL INTUBATION; FEMALE; HEMATOCRIT; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; NEUROMUSCULAR FUNCTION; PRIORITY JOURNAL; THROMBOCYTE COUNT; ULNAR NERVE; UREA NITROGEN BLOOD LEVEL;

ADULT; ANESTHESIA; BIOTRANSFORMATION; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; MONITORING, INTRAOPERATIVE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PHYSICAL STIMULATION; PROSPECTIVE STUDIES; ULNAR NERVE; VECURONIUM BROMIDE;

EID: 0034998383     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-8180(01)00253-7     Document Type: Article

References (16)

1. Bevan D.R., Donati F., Gyasi H., Williams A. Vecuronium in renal failure. Can Anaesth Soc J. 31:1984;491-496.
2. Hunter J.M., Jones R.S., Utting J.E. Comparison of vecuronium, atracurium and tubocurarine in normal patients and in patients with no renal function. Br J Anaesth. 56:1984;941-951.
3. Dhonneur G., Rebaine C., Slavov V., Ruggier R., De Chaubry V., Duvaldestin P. Neostigmine reversal of vecuronium neuromuscular block and the influence of renal failure. Anesth Analg. 82:1996;134-138.
4. Gramstad L. Atracurium, vecuronium and pancuronium in end-stage renal failure. Dose-response properties and interactions with azathioprine. Br J Anaesth. 59:1987;995-1003.
5. Sidi A., Kaplan R.F., Davis R.F. Prolonged neuromuscular blockade and ventilatory failure after renal transplantation and cyclosporine. Can J Anaesth. 37:1990;543-548.
6. Fahey M.R., Rupp S.M., Fisher D.M., et al. The pharmacokinetics and pharmacodynamics of atracurium in patients with and without renal failure. Anesthesiology. 61:1984;699-702.
7. Lynam D.P., Cronnelly R., Castagnoli K.P., et al. The pharmacodynamics and pharmacokinetics of vecuronium in patients anesthetized with isoflurane with normal renal function or with renal failure. Anesthesiology. 69:1988;227-231.
8. Takita K., Goda Y., Kemmotsu O., et al. Secondary hyperparathyroidism shortens the action of vecuronium in patients with chronic renal failure. Can J Anaesth. 42:1995;395-398.
9. Prielipp R.C., Jackson M.J., Coursin D.B. Comparison of the neuromuscular recovery after paralysis with atracurium versus vecuronium in an ICU patient with renal insufficiency. Anesth Analg. 78:1994;775-778.
10. Segredo V., Matthay M.A., Sharma M.L., Gruenke L.D., Caldwell J.E., Miller R.D. Prolonged neuromuscular blockade after long-term administration of vecuronium in two critically ill patients. Anesthesiology. 72:1990;566-570.
11. Beauvoir C., Peray P., Daures J.P., Peschaud J.L., D'Athis F. Pharmacodynamics of vecuronium in patients with and without renal failure a meta-analysis . Can J Anaesth. 40:1993;696-702.
12. Lepage J.Y., Malinge M., Cozian A., Pinaud M., Blanloeil Y., Souron R. Vecuronium and atracurium in patients with end-stage renal failure. A comparison study. Br J Anaesth. 59:1987;1004-1010.
13. Starsnic M.A., Goldberg M.E., Ritter D.E., Marr A.T., Sosis M., Larijani G.E. Does vecuronium accumulate in the renal transplant patient? Can J Anaesth. 36:1989;35-39.
14. Hunter J.M. Resistance to non-depolarizing neuromuscular blocking agents. Br J Anaesth. 67:1991;511-514.
15. Pollard B.J. Neuromuscular blocking drugs and renal failure. Br J Anaesth. 68:1992;545-547.
16. Henning R.H., Wierda J.M., Scaf A.H., Marescau B., De Deyn P.P., Agoston S. Increased sensitivity to vecuronium in patients with chronic renal failure. Drug Invest. 5:1993;98-107.